Zeneca

British multinational pharmaceutical company

Texto en inglés

Último precio

—

Precio mínimo

—

Mediana 7 d

—

Ventas 30 d

Rango 30 d

—

En circulación

Cotización

Ver tabla

Fecha	mediana	Mín	Máx	ventas

Historial de ventas

Última venta: —
Media 30 d: —
Mínimo 30 d: —
Máximo 30 d: —
Ventas 7 d: 0
Ventas 30 d: 0

Aún no hay ventas.

Ventas anónimas: sin comprador ni vendedor. Las cifras solo cuentan ventas entre jugadores.

En Wikipedia

Texto en inglés Aún no hay artículo en tu idioma: extracto en inglés.

Zeneca Group plc, trading as Zeneca, was a British multinational pharmaceutical company headquartered in London, England. It was formed in June 1993 by the demerger of the pharmaceuticals and agrochemicals businesses of Imperial Chemical Industries into a separate company listed on the London Stock Exchange. In 1999, Zeneca and the Sweden-based pharmaceutical company Astra AB merged to form AstraZeneca plc. Zeneca shareholders received 53.5% of the shares, while Astra shareholders received the remaining 46.5%. Zeneca's largest therapeutic area was oncology, in which its key products included Casodex, Nolvadex and Zoladex. Other key products included heart drug Tenormin.

Texto: Wikipedia en inglés, CC BY-SA 4.0. ·